Author Relationships With Industry and Other Entities (Relevant) 2014 Acc/Aha/Aats/Pcna/Scai/Sts Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section* Stephan D. Fihn (Chair) Department of Veterans Affairs Director, Office of Analytics and Business Intelligence None None None None None None None James C. Blankenship (Vice Chair) Geisinger Medical Center Staff Physician; Director, Cardiac Catheterization Laboratory None None None AstraZeneca None None 2.2.5 Boston Scientific 4.4.2 Kai Pharmaceutical 4.4.4 The Medicines Company Schering-Plough Volcano Karen P. Alexander Duke University Medical Center Associate Professor of Medicine/ Cardiology None None None Gilead Sanofi-aventis None 2.2.5 John A. Bittl Munroe Regional Medical Center Invasive Cardiologist None None None None None None None John G. Byrne Brigham and Women s Hospital Chief, Division of Cardiac Surgery None None None None None None None Barbara J. Fletcher University of North Florida Clinical Associate Professor, School of Nursing None None None None None None None Gregg C. Fonarow UCLA Cardiomyopathy Center Professor of Medicine Boston Scientific None None None None None 2.2.5 Johnson & Johnson The Medicines Company Medtronic Richard A. Lange University of Texas Health Science Center, San Antonio Professor of Medicine None None None None None None None Glenn N. Levine Baylor College of Medicine Professor of Medicine; Director, Cardiac Care Unit None None None None None None None Thomas M. Maddox VA Eastern Colorado Health Care System Cardiologist None None None None None None None Srihari S. Naidu Winthrop University Hospital Director, Cardiac Catheterization Laboratory None None None None None None None (Continued) Fihn et al 2014 Stable Ischemic Heart Disease Focused Update 1763 Appendix 1. Continued Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section* E. Magnus Ohman Duke Medicine Professor of Medicine AstraZeneca Gilead Sciences None Daiichi-Sankyo None None 2.2.5 Bristol-Myers Squibb Gilead Sciences Gilead Sciences The Medicines Company Merck Sanofi-aventis Peter K. Smith Duke University Medical Center Professor of Surgery; Chief, Thoracic Surgery None None None None None None None This table represents the relationships of writing group members with industry and other entities that were determined to be relevant to this document. 